Farmas USA

Así estamos. Momento complicado que se puede afianzar o ir al guano. Ahora se va a ver qué puede pasar.
AMRN se empieza a desperezar, a ver,,, la he visto claro en 14,80,,, hasta que no verdee no me he atrevido a más.

XBI 1h
será la buena?
vamosssss!!!

mirando lso holdings de XBI- parece que hoy tiran Seattle+12% , Abbv, 2% y supongo que algunas más,
-curioso que en el top 20 hay que no me suenan de nada, al menos a mi y que tienen peso 1,5-6% al lado de famosas.

NameHolding      -        Allocation |
Seattle Genetics, Inc. | 1.85%
AbbVie, Inc. | 1.83%
Ligand Pharmaceuticals Incorporated | 1.75%
Medicines Company | 1.74%
Celgene Corporation | 1.73%
United Therapeutics Corporation | 1.72%
Amgen Inc. | 1.72%
Mirati Therapeutics Inc. | 1.70%
Biogen Inc. | 1.67%
Regeneron Pharmaceuticals, Inc. | 1.67%
Alnylam Pharmaceuticals, Inc | 1.67%
Repligen Corporation | 1.65%
Vertex Pharmaceuticals Incorporated | 1.64%
Incyte Corporation | 1.64%
Spark Therapeutics, Inc. | 1.63%
Gilead Sciences, Inc. | 1.63%
BioMarin Pharmaceutical Inc. | 1.62%
Neurocrine Biosciences, Inc. | 1.61%
Exelixis, Inc. | 1.61%
Intercept Pharmaceuticals, Inc. | 1.60%
Blueprint Medicines Corp. | 1.60%
Global Blood Therapeutics Inc | 1.57%
Alexion Pharmaceuticals, Inc. | 1.57%
Arrowhead Pharmaceuticals, Inc. | 1.55%
SAGE Therapeutics, Inc. | 1.54%
Ionis Pharmaceuticals, Inc. | 1.53%
bluebird bio, Inc. | 1.52%
Sarepta Therapeutics, Inc. | 1.50%
Invitae Corp. | 1.50%
Exact Sciences Corporation | 1.48%
Amicus Therapeutics, Inc. | 1.39%
Biohaven Pharmaceutical Holding Company Ltd. | 1.39%
Genomic Health, Inc. | 1.29%
FibroGen, Inc. | 1.26%
Arena Pharmaceuticals, Inc. | 1.21%
ACADIA Pharmaceuticals Inc. | 1.21%
Portola Pharmaceuticals, Inc. | 1.20%
CareDx, Inc. | 1.17%
Immunomedics, Inc. | 1.16%
Iovance Biotherapeutics Inc | 1.15%
Alkermes Plc | 1.13%
Ultragenyx Pharmaceutical, Inc. | 1.12%
Insmed Incorporated | 1.11%
Myriad Genetics, Inc. | 1.08%
Agios Pharmaceuticals, Inc. | 1.07%
REGENXBIO, Inc. | 1.04%
Esperion Therapeutics, Inc. | 0.95%
Coherus BioSciences, Inc. | 0.85%
PTC Therapeutics, Inc. | 0.83%
Natera, Inc. | 0.81%
Madrigal Pharmaceuticals, Inc. | 0.78%
Allakos, Inc. | 0.78%
Veracyte Inc | 0.76%
ArQule, Inc. | 0.75%
Emergent BioSolutions Inc. | 0.74%
Alder Biopharmaceuticals, Inc. | 0.73%
Xencor, Inc. | 0.71%
Puma Biotechnology, Inc. | 0.70%
Editas Medicine, Inc. | 0.69%
Sangamo Therapeutics, Inc. | 0.66%
Enanta Pharmaceuticals, Inc. | 0.66%
Fate Therapeutics, Inc. | 0.64%
Halozyme Therapeutics, Inc. | 0.64%
Ra Pharmaceuticals, Inc. | 0.63%
Ironwood Pharmaceuticals, Inc. Class A | 0.62%
Heron Therapeutics Inc | 0.62%
Audentes Therapeutics, Inc. | 0.61%
Atara Biotherapeutics Inc | 0.58%
AnaptysBio, Inc. | 0.56%
Adverum Biotechnologies Inc | 0.54%
Acceleron Pharma Inc | 0.54%
Karyopharm Therapeutics, Inc. | 0.52%
Vanda Pharmaceuticals Inc. | 0.51%
Viking Therapeutics, Inc. | 0.48%
Athenex, Inc. | 0.48%
Aimmune Therapeutics Inc | 0.46%
G1 Therapeutics, Inc. | 0.45%
ZIOPHARM Oncology, Inc. | 0.44%
Allogene Therapeutics, Inc. | 0.43%
Radius Health Inc | 0.42%
Intrexon Corporation | 0.42%
Voyager Therapeutics, Inc. | 0.42%
AMAG Pharmaceuticals, Inc. | 0.42%
Retrophin, Inc. | 0.41%
Vericel Corporation | 0.40%
Apellis Pharmaceuticals, Inc. | 0.39%
Intellia Therapeutics, Inc. | 0.37%
Eagle Pharmaceuticals, Inc. | 0.36%
Epizyme, Inc. | 0.35%
TG Therapeutics, Inc. | 0.35%
Deciphera Pharmaceuticals, Inc. | 0.35%
Anika Therapeutics, Inc. | 0.34%
Stemline Therapeutics, Inc. | 0.34%
OPKO Health, Inc. | 0.34%
MacroGenics, Inc. | 0.31%
Dicerna Pharmaceuticals, Inc. | 0.30%
Flexion Therapeutics, Inc. | 0.30%
Spectrum Pharmaceuticals, Inc. | 0.29%
Twist Bioscience Corp. | 0.28%
Momenta Pharmaceuticals, Inc. | 0.28%
Krystal Biotech, Inc. | 0.25%
Turning Point Therapeutics, Inc. | 0.25%
Denali Therapeutics Inc. | 0.24%
Catalyst Pharmaceuticals, Inc. | 0.24%
Kura Oncology, Inc. | 0.24%
ImmunoGen, Inc. | 0.23%
BioCryst Pharmaceuticals, Inc. | 0.23%
Cytokinetics, Incorporated | 0.22%
Progenics Pharmaceuticals, Inc. | 0.18%
Homology Medicines, Inc. | 0.17%
Achillion Pharmaceuticals, Inc. | 0.17%
Rhythm Pharmaceuticals, Inc. | 0.16%
Akcea Therapeutics, Inc. | 0.15%
Akebia Therapeutics, Inc. | 0.15%
CytomX Therapeutics, Inc. | 0.13%
Rocket Pharmaceuticals, Inc. | 0.13%
AVROBIO Inc | 0.12%
Prothena Corp. Plc | 0.08%

b2k actualiza precios:
 

Finally starting to see some cheap stocks. I don't think it ends until everything is cheap. I think the XBI down side is $75 to $71. Its close enough that you should be nibbling at least something. Just don't go all in just in case we go back to the December lows of last year at $64 on the XBI.

Mis compras de hoy AMRN 15,2 (podría ser paquete único o no ) y PBYI 10,6 ( paquete único y stop cercano).
Y por si te interesa y animas, @Cosmo, dentro CLF también ;)

XBI … Durante un buen tiempo de sesión hemos tenido una vela verde aquí … que no ha sido el caso ya para el cierre … curioso el minimo de hoy … los 75,62 … coincidentes con el ultimo retroceso fibo … ojala aguante … 

Alguien sigue a Acorda (ACOR) ?

TEVA

Sube por
 

 by taking part in Purdue Pharma's bankruptcy. 

Johnson & Johnson (NYSE:JNJ), Teva (NYSE:TEVA), Endo International (NASDAQ:ENDP), Allergan (NYSE:AGN) and Mallinckrodt (NYSE:MNK) are pursuing a global settlement of litigation through Purdue's Chapter 11 case, according to the report. 

That would be through contributing to a trust in the case in exchange for release from liability. 

The mechanism is not dissimilar to one available to automakers in the Takata defective airbag litigation. 

It would need buy-in not only from Purdue and the owning Sackler family but also a critical mass of state AGs and suing municipalities -- and there are some 2,500 lawsuits brought by virtually every state along with local governments and Native American tribes. 

https://seekingalpha.com/news/3502762-drugmakers-pursue-new-plan-wrap-opioid-suits?ifp=0